Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Original Article from The New England Journal of Medicine — Effects of Intensive Glucose Lowering in Type 2 Diabetes. UKPDS overview. 1. The UK Prospective Diabetes Study ukpds; 2. • year multicenter RCT -Interventional Trial from to • Intensive.
|Published (Last):||26 April 2005|
|PDF File Size:||14.60 Mb|
|ePub File Size:||16.42 Mb|
|Price:||Free* [*Free Regsitration Required]|
The lowcarbohydrate, ketogenic diet lckd may be effective for improving glycemia and reducing medications in patients with type 2 diabetes.
There was a problem providing the content you requested
Until now there has been little convincing evidence that improved diabetes control will prevent the complications of diabetes. No threshold was seen, i. In people with Type 2 diabetes that is usually diagnosed in middle age, symptoms can often be controlled by diet or tablet therapy. Clearly, achieving this goal will require aggressive follow up patients in the UKPDS were seen 3 monthlyand this may not be acceptable to all patients.
The benefits of treatment? It also needs to be on a large scale, studying large numbers of patients, to obtain a reliable answer. Reappraisal of metformin efficacy in the treatment of type 2. Inthe study of treatment of hypertension was started. In trials such as this, patients are selected both by investigators and by themselves. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
The study was set up so that physicians could have a sound basis for deciding which treatments they should prescribe to patients.
Different agents seemed equally effective, but the possibility of type 2 errors in these subgroup analyses cannot be excluded, as already discussed. This article has been cited by other articles in PMC.
The UKPDS showed no difference in outcome between treatments, which is at first sight reassuring, but the study was powered to assess the effects of intensive therapy in general and it is unclear whether there is adequate power in this subgroup analysis. Improved blood-glucose eestudio decreases the progression of diabetic microvascular disease, but the effect on macrovascular complications is unknown.
Overweight people could also be randomised to a tablet called metformin, as an additional option. Single clinical endpoints and upds subclinical endpoints were also assessed.
In addition to general articles on clinical aspects of diabetes mellitus, journal of diabetes and its complications also presents articles on basic research in all. The results of metformin treatment are the most controversial [ 14 ]. In addition, no larger scale studies had been done to show whether improved blood pressure control was effective. Intensive glucose control significantly reduced any diabetes-related end point, but had no effect on mortality.
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. These also demonstrated a reduction in macrovascular risk, including myocardial infarction [ 2021 ].
We compared the effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial. In addition, the few clinical trials that have been done have raised the possibility that some of the commonly used treatments may aggravate damage to large arteries.
Thus, unlike blood pressure control, intensive glycaemic control is not suitable for all patients, particularly the elderly, or those with existing severe complications.
One aspect of management inadequately addressed by the study is the optimal combination of drugs to be used either for glucose or blood pressure control. Author information Article notes Copyright and License information Disclaimer.
Mortality and survival in type II non-insulin dependent diabetes mellitus. Economic evaluations of Type II diabetes. Therapeutic implications, study limitations and outstanding questions Figures 5 — jkpds. Thus there is no doubt of the significance of blood pressure control in type 2 diabetes, but there remains the question whether particular drugs have advantages or disadvantages. There was also a trend, just short of statistical significance, towards a reduction in macrovascular disease.
UK Prospective Diabetes Study : Protocol
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: This has been an acceptable clinical practice, in view of the lack of reliable evidence to show that intensive treatment of blood glucose or blood pressure will prevent complications, and thus help to maintain the health of patients.
UK Prospective Diabetes Study UKPDS was a unique, long-term clinical trial designed to find out how to treat people with Type 2 diabetes to prevent complications and to maintain their health.
Asian patients are known to be more predisposed to dn and esrd than. Each of these treatments has u,pds been shown to be advantageous. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. However, glucose levels usually remain high and these can lead to “diabetic complications”. Therefore inan ukkpds study was set up in over people with diabetes and ukprs high blood pressure.
As esttudio as diabetes is diagnosed, to give best chance of preventing complications. Type 2 diabetes mellitus t2dm is a chronic disease that affects. These strengthened the study by broadening its scope, but at the cost of complicating the treatment allocation, conduct and analysis of the study.
Effects of enalapril on mortality in severe congestive heart failure.